Big Picture Bio

Big Picture Bio is developing AI-designed combination therapies for cancer and other complex diseases

Biotech & Life Sciences

Sector

Seed

Stage

B2B SaaS for drug discovery

Model

01Company Overview

Big Picture Bio is developing AI-designed combination therapies for cancer and other complex diseases. Its generative world model is designed to understand how tumours, immune cells and surrounding tissue interact, enabling the identification and optimisation of promising drug combinations before they enter the clinic.

02Backed By2 investors

EVExceptional Ventures→KCKadmos Capital→

03

Is this your company? Claim your profile

Companies with the same backers

1 company

GlycanAgeHealthcare & Digital Health

Exceptional Ventures, Kadmos Capital

Find the investors for your round

04Recent Activity

FROM Kadmos Capital

Co-led Big Picture Bio's £1.5M pre-seed round to build AI-designed cancer combination therapies.